2-oxindole has been researched along with Glioblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borghini, A; Breschi, MC; Calderone, V; Daniele, S; Digiacomo, M; Falasca, M; Lapucci, A; Macchia, M; Martelli, A; Martini, C; Nesi, G; Notarangelo, A; Parrella, P; Pietra, D; Rapposelli, S; Sestito, S | 1 |
1 other study(ies) available for 2-oxindole and Glioblastoma
Article | Year |
---|---|
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
Topics: Cell Count; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Glioblastoma; Humans; Indoles; Molecular Structure; Oxindoles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Structure-Activity Relationship | 2015 |